Alkemist Bio

Developer of cellular immunotherapies for ALK-positive cancers

placeTurin, Piedmont, Italy calendar_todayFounded 2023 language alkemistbio.com

Social engagement

Social engagement: 763 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Claris Ventures.

Investor typeCountShare
Venture capital267%
Angel & family office133%

Recent activity

8 Jun 2026
Leadership hire
Chief Executive Officer
Coming soon